Supplement × Supplement·a caution·Insufficient evidence

Larazotide Acetate + Quercetin

Caution Insufficient evidence

Quercetin is often used for barrier or mast-cell claims and can confound symptom tracking.

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Pair type
Caution
Evidence
Insufficient
Source citations
1
Scope
Supplement × Supplement
Last verified
June 4, 2026
CautionInsufficient evidence

What is happening. Quercetin is often used for barrier or mast-cell claims and can confound symptom tracking.

Mechanism. Overlapping gut barrier marketing claims.

Recommendation. Avoid unsupported multi-agent leaky-gut stacks.

Stack Score

How it moves the number.

Effect on the composite score

If both Larazotide Acetate and Quercetin are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Reference material

1
  • 19 Meters Biopharma. Larazotide phase 3 interim analysis. 2022.Needs sourceNo link

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.